Drugs / SAR439065
last change Sep 2015 re-read 2 minutes ago

SAR439065

Developed for
type 1 diabetes mellitus
Investigated by
Mannkind Corporation

Trials 1 · a red edge is where a trial was stopped

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02470637 Jun → Sep 2015 type 1 diabetes mellitus Mannkind Corporation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SAR439065 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02470637